Air Voel, one of Canada’s leading providers of CPAP machines, masks, and sleep-health solutions, today announced the launch of its Sleep Better 2026 Initiative, a nationwide program designed to raise ...

Eli Lilly posts 54% revenue growth with Zepbound, Mounjaro, expanding pipeline, and rising market share. Learn why LLY stock ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer's disease in closely watched trials.

As the holiday season approaches, respiratory health becomes a top priority for individuals living with chronic conditions such as COPD, sleep apnea, or other lung diseases. VARON, a leading provider ...

Ozempic, and the class of weight loss drugs it has come to embody, has left its imprint seemingly everywhere: On the lives of ...

Cipla's wants to create awareness, help diagnostics, provide solutions and rehab support, COO Achin Gupta tells Moneycontrol, as the firm doubls down on its lung-care strategy ...

This application is based on the encouraging results from the Phase 3 registration clinical study GLORY-2 (NCT06164873) of mazdutide 9 mg in Chinese adults with moderate to severe obesity. The study ...

On November 25, 2025, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced ...

Ozempic 2.0 and the next generation of GLP-1 drugs promise stronger, more convenient weight loss options, from daily pills to ...

For many years, the narrative surrounding obesity in the United States has been one of relentless increase. From the ...

A new study found that getting CPAP treatment within the first two years of a sleep apnea diagnosis reduced the risk of ...

Early treatment of obstructive sleep apnea may decrease the risk of Parkinson's disease, a new study published Monday finds.